Table 1 of
Wang, Mol Vis 2019; 25:912-920. Table 1 of
Wang, Mol Vis 2019; 25:912-920.
Table 1. Clinical features of recruited patients.
| Patient ID | Age (years) /Sex | Onset Age (years) | BCVA (logMAR) | Optic disc | VEP | |
|---|---|---|---|---|---|---|
| OD | OS | |||||
| OA01-II:3 | 60/F | 3 | 0.02 | 0.01 | Pale | NA |
| OA01-III:1 | 38/M | 8 | 0.1 | 0.1 | Pale | NA |
| OA01-IV:1 | 16/F | 5 | 0.05 | 0.05 | Pale | NA |
| OA02-II:2 | 30/F | Infant | 0.25 | 0.02 | Pale | Diminished |
| OA03-II:1 | 8/M | 3 | 0.2 | 0.3 | Pale | NA |
| OA04-II:2 | 10/M | 6 | 0.5 | 0.5 | Pale | NA |
| OA05-II:1 | 10/M | 6 | 0.4 | 0.5 | Pale | NA |
| OA06-I:1 | 42/M | 12 | 0.5 | 0.4 | Pale | NA |
| OA06-II:1 | 14/F | 11 | 0.2 | 0.1 | Pale | NA |
| OA07-II:2 | 9/M | 4 | 0.4 | 0.3 | Pale | NA |
| OA08-I:1 | 32/M | 8 | 0.3 | 0.3 | Pale | Diminished |
| OA08-II:1 | 9/M | 5 | 0.5 | 0.4 | Pale | Diminished |
| OA09-II:1 | 8/M | 5 | 0.1 | 0.1 | Pale | NA |
| OA10-II:2 | 9/M | 7 | 0.2 | 0.2 | Pale | NA |
| OA11-II:1 | 43/F | 12 | 0.1 | 0.1 | Pale | NA |
| OA11-II:2 | 42/F | 10 | 0.1 | 0.1 | Pale | NA |
| OA12-I:1 | 30/M | 8 | 0.3 | 0.3 | Pale | Diminished |
| OA12-II:1 | 6/M | 4 | 0.3 | 0.3 | Pale | Diminished |
| OA13-I:2 | 31/F | 6 | 0.4 | 0.4 | Pale | NA |
| OA13-II:1 | 7/M | 4 | 0.3 | 0.3 | Pale | NA |
| OA14-I:2 | 28/F | 6 | 0.3 | 0.4 | Pale | NA |
| OA14-II:1 | 6/M | 3 | 0.25 | 0.3 | Pale | NA |
| OA15-II:1 | 14/M | 6 | 0.2 | 0.2 | Pale | NA |